Illustrative image (Photo: VNA) Hanoi (VNA) – Domestic medicines are expected to meet75 percent of demand and 60 percent of market value by 2025, according to aprogramme on the development of the pharmaceutical industry and medicines fordomestic production till 2030 with a vision to 2045.
Recently approved by the Prime Minister, the programme set theoverall goal of building the domestic pharmaceutical industry to level 4according to the World Health Organisation (WHO)’s classification, the top 3 interms of market value in ASEAN, contributing to ensuring the timely andsufficient supply of safe, quality and effective medicines at reasonableprices.
It also targets developing medicines into a quality and high-valueindustry that is competitive at home and abroad.
By 2025, the rate of using pharmaceuticals of domestic origin will increase byat least 10 percent from 2020.
At the same time, Vietnam will build eight zones for sustainableexploitation of natural medicinal sources, two to five cultivation areas on a large scale. Each ofthem will have one to two linkage chains of research, farming and processing followingthe WHO’s Guidelines on Good Agricultural and Collection Practices.
By early 2030, Vietnam sets to become a pharmaceuticalproduction hub in the region with a total value of nearly 1 billion USD.
To such end, the programme also set out measures regardinginstitutions, laws, investment, competitiveness improvement, science-technology,workforce training, control of medicine and pharmaceutical market,international cooperation and integration, information and communications.
Accordingly, at least two national-level science-technologytasks using the State budget will be performed in three years while at leastfive ministry-level pharmaceutical development tasks will be undertaken in oneyear, focusing on research and production of vaccines as well as nationalproducts using domestic medicinal sources./.
